The Joint Corp. (JYNT)
Healthcare
- Fundamental
- 3
- Sentiment
- 2
- Technical
- 1
Do Nothing: qualitativeScore 2 is below the required floor of 3 (shadow branch not eligible — flag false); liquidity also fails — avgDollarVolume20 $813,188 < $5M floor and recent 3-session regular-session volume ~$719K < $1.5M floor; the chart adds no entry — a pullback limit would be countertrend (price < SMA50 with MACD < 0) and no breakout stop qualifies (price below the full MA stack at a 52-week-low retest).
Company overview
The Joint Corp. operates chiropractic treatment centers, divided into corporate-owned clinics and franchised facilities. The company uses direct ownership, management agreements, and franchising to expand its presence, with approximately 700 locations in the U.S. as of March 2022. Founded in 2010, it is headquartered in Scottsdale, Arizona.
Fundamental
fairThe Joint Corp. shows a strong balance sheet and insider buying, but faces declining sales and legal uncertainties.
Mixed fundamentals during a strategic transition: The Joint Corp. pairs a net-cash balance sheet, growing franchise revenue, a cured credit-facility default, and consistent insider buying against thin continuing-operations earnings, declining comparable and system-wide sales, a history of restatements, unquantified California litigation, and DCF estimates below the current price. Net verdict: mixed / uncertain - a watchlist candidate rather than a clear buy or avoid.
Sentiment
weakThere is no significant media or retail sentiment, and no actionable catalysts are present.
No catalyst qualifies for the actionable window: the territory-reacquisition PR (wire-announced) is extraction-limited with is_material=false and type 'mna', outside the materiality-override classes, so it remains context-only. The media delta is indeterminate (baseline on-topic sample below three unique items after primary and aggregator pulls), retail coverage is absent, and the Red-Flag Screen fired no severe or moderate flags (no cap applied) - an Absent, non-actionable setup.
Technical
very weakThe stock is in a persistent downtrend with no bullish confirmations or valid entry points.
Bearish structure with no bullish confirmations: price 7.11 sits below SMA20 8.01, SMA50 8.24 and SMA200 8.76, and below the entire short stack (EMA9 7.56, EMA21 7.89, WMA9 7.43, WMA21 7.85, DEMA14 7.36, TEMA14 7.16); MACD -0.30/-0.17/-0.12 negative with the histogram widening; RSI14 24.73 and Williams %R -96.36 deeply oversold but no reversal signal; ADX14 19.14 rising while price is under all MAs — a developing down-trend, not a bullish base. The stock has ground lower from the 09-22 high 8.62 into a retest of the 52-week low 7.045 (today's low 7.05, close 7.11). Blocked regardless of the chart: qualitativeScore 2 (below the floor of 3; shadow branch not eligible — flag false) and both liquidity gates fail (avgDollarVolume20 $813,188 < $5M; recent 3-session regular volume ~$719K < $1.5M).
You’re looking at 2026-10-06 — more than 2 trading days ago.
Subscribers saw this then, and see today’s score, verdict and trade plan now.
More Healthcare
Not financial advice. For informational and educational purposes only.

